Literature DB >> 11801513

Does radiotherapy have a role in the management of thyroid orbitopathy? View 1.

Kimberley P Cockerham1, John S Kennerdell.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11801513      PMCID： PMC1770958     

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  30 in total

1.  Diabetes mellitus: a risk factor in patients with Graves' orbitopathy.

Authors:  R Kalmann; M P Mourits
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

2.  Radiation therapy for Graves' ophthalmopathy: trick or treat?

Authors:  S E Feldon
Journal:  Ophthalmology       Date:  2001-09       Impact factor: 12.079

3.  Orbital X-ray therapy of progressive exophthalmos.

Authors:  A JONES
Journal:  Br J Radiol       Date:  1951-12       Impact factor: 3.039

4.  Eyelid and orbital fascial attachments and their clinical significance.

Authors:  L Koornneef
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

5.  Place of radiotherapy in the treatment of Graves' orbitopathy.

Authors:  V Beckendorf; T Maalouf; J L George; P Bey; J Leclere; E Luporsi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-03-01       Impact factor: 7.038

6.  Intravenous methylprednisolone pulse therapy in the treatment of Graves' ophthalmopathy.

Authors:  G Matejka; B Vergès; G Vaillant; J M Petit; A Brun-Pacaud; S Rudoni; J M Brun
Journal:  Horm Metab Res       Date:  1998-02       Impact factor: 2.936

7.  A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.

Authors:  C A Gorman; J A Garrity; V Fatourechi; R S Bahn; I A Petersen; S L Stafford; J D Earle; G S Forbes; R W Kline; E J Bergstralh; K P Offord; D M Rademacher; N M Stanley; G B Bartley
Journal:  Ophthalmology       Date:  2001-09       Impact factor: 12.079

8.  Radiation therapy for thyroid eye diseases.

Authors:  T Hurbli; D H Char; J Harris; K Weaver; F Greenspan; G Sheline
Journal:  Am J Ophthalmol       Date:  1985-06-15       Impact factor: 5.258

9.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Authors:  M P Mourits; L Koornneef; W M Wiersinga; M F Prummel; A Berghout; R van der Gaag
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

10.  Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.

Authors:  L Bartalena; C Marcocci; L Chiovato; M Laddaga; G Lepri; D Andreani; G Cavallacci; L Baschieri; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958
View more
  5 in total

Review 1.  An update on medical management of Graves' ophthalmopathy.

Authors:  L Bartalena; C Marcocci; M L Tanda; E Piantanida; A Lai; M Marinò; A Pinchera
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

2.  Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?

Authors:  L Bartalena; C Marcocci; C A Gorman; W M Wiersinga; A Pinchera
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

3.  Age differences in clinical manifestation and prognosis of thyroid eye disease.

Authors:  Guy J Ben Simon; Gabriel Katz; Ofira Zloto; Hana Leiba; Beatrix Hadas; Ruth Huna-Baron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-07       Impact factor: 3.117

4.  Enhancement of viability of radiosensitive (PBMC) and resistant (MDA-MB-231) clones in low-dose-rate cobalt-60 radiation therapy.

Authors:  Patrícia Lima Falcão; Bárbara Miranda Motta; Fernanda Castro de Lima; Celso Vieira Lima; Tarcísio Passos Ribeiro Campos
Journal:  Radiol Bras       Date:  2015 May-Jun

5.  Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial.

Authors:  Rathie Rajendram; Richard W J Lee; Mike J Potts; Geoff E Rose; Rajni Jain; Jane M Olver; Fion Bremner; Steven Hurel; Anne Cook; Rao Gattamaneni; Marjorie Tomlinson; Nicholas Plowman; Catey Bunce; Sandra P Hollinghurst; Laura Kingston; Sue Jackson; Andrew D Dick; Nichola Rumsey; Olivia C Morris; Colin M Dayan; Jimmy M Uddin
Journal:  Trials       Date:  2008-01-31       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.